DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

TRANSPEK vs VITAL: Stock Comparison

TRANSPEK INDUSTRY vs VITAL CHEMTECHUpdated 13 Nov 26, 4:08 PM ISTNSE & company filings

TRANSPEK INDUSTRY shows a lower P/E, a higher dividend yield and lower leverage, while VITAL CHEMTECH shows a higher ROE and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

TRANSPEK leads 8; VITAL leads 3 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

TRANSPEKVITAL

Valuation lens

What price are you paying?

Market CapContext only
₹748 Cr
—
P/E RatioTRANSPEK has the lower reading
15.95x ✓
32.07x
P/B RatioTRANSPEK has the lower reading
0.94x ✓
1.4x
EPSTRANSPEK has the higher reading
₹36.82 ✓
₹0.98
Book ValueContext only
₹1,373.97
₹41.74
Dividend YieldTRANSPEK has the higher reading
1.49% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
TRANSPEK has a lower P/E
15.95x vs 32.07x
P/B Ratio
TRANSPEK has a lower P/B
0.94x vs 1.4x
EPS
TRANSPEK has higher earnings per share
₹36.82 vs ₹0.98
Dividend Yield
TRANSPEK has a higher dividend yield
1.49% vs 0%
Qtr Sales Growth
TRANSPEK has stronger quarterly sales growth
28.13% vs -2.36%
Qtr Profit Growth
TRANSPEK has stronger quarterly profit growth
130.36% vs -1.73%
ROE
VITAL has a higher ROE
7.95% vs 5.95%
ROCE
VITAL has a higher ROCE
8.3% vs 6.87%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricTRANSPEKVITAL
Live Price₹1,360.2₹51
Day Change1.79%-1.92%
Volume2,0345,097
52-Week High₹1,447.9₹69.4
52-Week Low₹952.3₹35.4
Distance from 52W High-6.06%-26.51%

Valuation

MetricTRANSPEKVITAL
Market Cap₹748 Cr—
P/E Ratio15.95x32.07x
P/B Ratio0.94x1.4x
EPS₹36.82₹0.98
Book Value₹1,373.97₹41.74
Dividend Yield1.49%0%

Growth

MetricTRANSPEKVITAL
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth28.13%-2.36%
Qtr Profit Growth130.36%-1.73%

Profitability & Leverage

MetricTRANSPEKVITAL
ROE5.95%7.95%
ROCE6.87%8.3%
Net Margin7.35%0.81%
Operating Margin11.15%11.38%
Debt to Equity0.06x0.1x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricTRANSPEKVITAL
Promoter Holding57.27%73.43%
FII Holding0.02%1.62%
DII Holding1.05%▼ 0.55 pp0.25%
Public Holding41.66%▲ 0.75 pp24.7%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: TRANSPEK INDUSTRY and VITAL CHEMTECH.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.